de Baat, E. C., van Dalen, E. C., Mulder, R. L., Hudson, M. M., Ehrhardt, M. J., Engels, F. K., . . . Armenian, S. (2022). Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines: Recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet.Child & adolescent health, 6(12), 885-894.

de Baat, Esmée C., et al. "Primary Cardioprotection with Dexrazoxane in Patients with Childhood Cancer Who Are Expected to Receive Anthracyclines: Recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group." Lancet.Child & Adolescent Health 6, no. 12 (2022): 885-894.

de Baat, Esmée C., et al. "Primary Cardioprotection with Dexrazoxane in Patients with Childhood Cancer Who Are Expected to Receive Anthracyclines: Recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group." Lancet.Child & Adolescent Health, vol. 6, no. 12, 2022, pp. 885-894.